Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes

9 augusti 2021 uppdaterad av: Joslin Diabetes Center

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes: A Pilot Study

This study is evaluating how to encourage teens to engage in heart healthy behaviors such as being more active or eating in a healthy way. Teens will be randomly assigned to either the usual care group or the group with education, goal-setting, and lifestyle challenges with teammates.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

Specific Aim: To develop and pilot test a modular intervention to improve heart healthy self-efficacy and behaviors in teens with type 1 diabetes at elevated cardiovascular disease risk.

Intervention Objective: To evaluate the feasibility and efficacy of a psychoeducational and behavioral intervention to improve heart healthy self-efficacy and behaviors in youth with type 1 diabetes (T1D) at elevated cardiovascular disease (CVD) CVD risk.

Secondary Objective: Assess participation in challenges involving healthy eating and physical activity.

Synopsis of Study Design

Study Design: Randomized, attention-matched trial with 1:1 randomization at a single center. Subjects will be randomized in two strata, by age (14-16 years and 17-19 years).

Study Population: Teens with type 1 diabetes.

Intervention: This pilot study involves a 6-month randomized controlled trial (RCT) comparing 2 study conditions, the behavioral intervention vs. an attention control. Youth will be randomized in 2 strata, by age (14-16 years and 17-19 years). Enrollment will end after 60 participants.

The intervention group will receive 2 modules (one in in person and one by video conference) and will receive follow-up phone calls/emails by study staff 3 weeks following each visit to review education and strategies for and barriers to reaching goals. Intervention sessions must include teen; parents may attend if they wish. Challenges will occur every 2 weeks. Participants will be on teams of about 3-5 teens and the teams may change over the course of the intervention due to staggered enrollment. As team members finish the study, newly randomized teammates will be assigned.

There will be a delayed intervention for the control group with study handouts after 3 months. The control group will meet with the research assistants (RAs) for demographic and survey completion and receive reminder phone calls/emails in order to match for attention.

Studietyp

Interventionell

Inskrivning (Faktisk)

45

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02215
        • Joslin Diabetes Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

14 år till 19 år (Barn, Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Teens ages 14-19 years old with T1D for ≥6 months
  • Current patients at Joslin Diabetes Center
  • Teens will have dyslipidemia (defined as LDL ≥100 mg/dl, HDL <40 mg/dl or triglycerides ≥130 mg/dl in past year), overweight or obesity (BMI percentile ≥85th at screening), prehypertensive or hypertensive blood pressure on day of screening visit, or A1c ≥8.0%
  • Youth and parents must be English speaking, without significant learning disabilities, and intend to continue care at our center.
  • Access to a smart phone with video conferencing capabilities

Exclusion Criteria:

  • Participation in an interventional study within the past 3 months.
  • Unwilling to comply with study procedures
  • Prescribed BP and/or lipid-lowering medications (besides over-the-counter supplements)
  • Contraindication to exercise

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Heart healthy intervention
The intervention group will receive 2 modules (one in in person and one by video conference) and will receive follow-up phone calls/emails by study staff 3 weeks following each visit to review education and strategies for and barriers to reaching goals. Intervention sessions must include teen; parents may attend if they wish. Participants will be placed on teams and encouraged to complete behavioral challenges to earn points towards a cash reward.
Intervention consists of educational modules, goal setting and brainstorming around strategies and barriers, and a series of heart healthy challenges such as walking a certain number of steps or eating healthy foods a certain number of times in a week.
Inget ingripande: Attention Control
There will be a delayed intervention for the control group with study handouts after 3 months. The control group will meet with the RAs for demographic and survey completion and receive reminder phone calls/emails in order to match for attention.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Adolescent Food Habits Checklist
Tidsram: 3 months
healthy eating questionnaire, 23 question true/false survey, score range from 0-23, higher scores indicate healthier habits, no subscales.
3 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Adiposity
Tidsram: 3 months
changes in zbmi
3 months
Blood pressure
Tidsram: 3 months
Changes in blood pressure percentile
3 months
Changes in lipid levels
Tidsram: 3 months
Changes in lipid levels from before study until study end
3 months
Activity level
Tidsram: 3 months
Documentation of how active participants were during study
3 months
Exercise Confidence Survey
Tidsram: 3 months
evaluation of self-efficacy for exercise
3 months
Healthy Eating Self-Efficacy Survey
Tidsram: 3 months
healthy eating self-efficacy measure
3 months
Eating Habits Confidence Survey
Tidsram: 3 months
evaluation of how confident participants are that they can eat in a healthy way
3 months
Acceptance of medication for CVD risk survey
Tidsram: 3 months
brief questions to evaluate willingness to take medication if prescribed
3 months
Engagement with behavioral challenges
Tidsram: 3 months
Proportion of intervention participants who completed challenges
3 months
Change in weight
Tidsram: 3 months
change in weight in kg between enrollment and study completion
3 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Lori Laffel, Joslin Diabetes Center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

3 maj 2018

Primärt slutförande (Faktisk)

8 februari 2019

Avslutad studie (Faktisk)

8 februari 2019

Studieregistreringsdatum

Först inskickad

26 april 2018

Först inskickad som uppfyllde QC-kriterierna

9 maj 2018

Första postat (Faktisk)

21 maj 2018

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

10 augusti 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

9 augusti 2021

Senast verifierad

1 augusti 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Heart healthy intervention

3
Prenumerera